Many studies have shown that the administration of GnRH-a in women with stage III-IV endometriosis for 3–6 cycles could reduce the recurrence of endometriosis and improve the pregnancy outcomes of infertile women before IVF/ICSI (intracytoplasmic sperm injection) [26]. Here, GNRH1 is linked to endometriosis.